0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Velpatasvir API Market Research Report 2025
Published Date: February 2025
|
Report Code: QYRE-Auto-36T11522
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global Velpatasvir API Market Research Report 2022
BUY CHAPTERS

Global Velpatasvir API Market Research Report 2025

Code: QYRE-Auto-36T11522
Report
February 2025
Pages:87
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Velpatasvir API Market Size

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years.

Velpatasvir API Market

Velpatasvir API Market

The global market for Velpatasvir API was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Velpatasvir(CAS:1377049-84-7) is an NS5A inhibitor (by Gilead) which is used together with sofosbuvir in the treatment of hepatitis C infection of all six major genotypes.
The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Velpatasvir API, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Velpatasvir API.
The Velpatasvir API market size, estimations, and forecasts are provided in terms of output/shipments (Kg) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Velpatasvir API market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Velpatasvir API manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, production, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of Velpatasvir API Market Report

Report Metric Details
Report Name Velpatasvir API Market
CAGR 5%
by Type
  • Above 98 %
  • Above 99 %
by Application
  • Tablets
  • Others
Production by Region
  • North America
  • India
  • China
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Mylan, NEWEDGE Overseas, Hetero Drugs, Mangalam Drugs & Organics Ltd, Aspen Biopharma Labs, Aspire Lifesciences Pvt Ltd, Changzhou Pharmaceutical Factory, Bulat Pharmaceutical
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Velpatasvir API manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Production/output, value of Velpatasvir API by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
  • Chapter 4: Consumption of Velpatasvir API in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
  • Chapter 5: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 6: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
  • Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 10: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Velpatasvir API Market report?

Ans: The main players in the Velpatasvir API Market are Mylan, NEWEDGE Overseas, Hetero Drugs, Mangalam Drugs & Organics Ltd, Aspen Biopharma Labs, Aspire Lifesciences Pvt Ltd, Changzhou Pharmaceutical Factory, Bulat Pharmaceutical

What are the Application segmentation covered in the Velpatasvir API Market report?

Ans: The Applications covered in the Velpatasvir API Market report are Tablets, Others

What are the Type segmentation covered in the Velpatasvir API Market report?

Ans: The Types covered in the Velpatasvir API Market report are Above 98 %, Above 99 %

1 Velpatasvir API Market Overview
1.1 Product Definition
1.2 Velpatasvir API by Type
1.2.1 Global Velpatasvir API Market Value Growth Rate Analysis by Type: 2024 VS 2031
1.2.2 Above 98 %
1.2.3 Above 99 %
1.3 Velpatasvir API by Application
1.3.1 Global Velpatasvir API Market Value Growth Rate Analysis by Application: 2024 VS 2031
1.3.2 Tablets
1.3.3 Others
1.4 Global Market Growth Prospects
1.4.1 Global Velpatasvir API Production Value Estimates and Forecasts (2020-2031)
1.4.2 Global Velpatasvir API Production Capacity Estimates and Forecasts (2020-2031)
1.4.3 Global Velpatasvir API Production Estimates and Forecasts (2020-2031)
1.4.4 Global Velpatasvir API Market Average Price Estimates and Forecasts (2020-2031)
1.5 Assumptions and Limitations
2 Market Competition by Manufacturers
2.1 Global Velpatasvir API Production Market Share by Manufacturers (2020-2025)
2.2 Global Velpatasvir API Production Value Market Share by Manufacturers (2020-2025)
2.3 Global Key Players of Velpatasvir API, Industry Ranking, 2023 VS 2024
2.4 Global Velpatasvir API Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.5 Global Velpatasvir API Average Price by Manufacturers (2020-2025)
2.6 Global Key Manufacturers of Velpatasvir API, Manufacturing Base Distribution and Headquarters
2.7 Global Key Manufacturers of Velpatasvir API, Product Offered and Application
2.8 Global Key Manufacturers of Velpatasvir API, Date of Enter into This Industry
2.9 Velpatasvir API Market Competitive Situation and Trends
2.9.1 Velpatasvir API Market Concentration Rate
2.9.2 Global 5 and 10 Largest Velpatasvir API Players Market Share by Revenue
2.10 Mergers & Acquisitions, Expansion
3 Velpatasvir API Production by Region
3.1 Global Velpatasvir API Production Value Estimates and Forecasts by Region: 2020 VS 2024 VS 2031
3.2 Global Velpatasvir API Production Value by Region (2020-2031)
3.2.1 Global Velpatasvir API Production Value by Region (2020-2025)
3.2.2 Global Forecasted Production Value of Velpatasvir API by Region (2026-2031)
3.3 Global Velpatasvir API Production Estimates and Forecasts by Region: 2020 VS 2024 VS 2031
3.4 Global Velpatasvir API Production Volume by Region (2020-2031)
3.4.1 Global Velpatasvir API Production by Region (2020-2025)
3.4.2 Global Forecasted Production of Velpatasvir API by Region (2026-2031)
3.5 Global Velpatasvir API Market Price Analysis by Region (2020-2025)
3.6 Global Velpatasvir API Production and Value, Year-over-Year Growth
3.6.1 North America Velpatasvir API Production Value Estimates and Forecasts (2020-2031)
3.6.2 India Velpatasvir API Production Value Estimates and Forecasts (2020-2031)
3.6.3 China Velpatasvir API Production Value Estimates and Forecasts (2020-2031)
4 Velpatasvir API Consumption by Region
4.1 Global Velpatasvir API Consumption Estimates and Forecasts by Region: 2020 VS 2024 VS 2031
4.2 Global Velpatasvir API Consumption by Region (2020-2031)
4.2.1 Global Velpatasvir API Consumption by Region (2020-2025)
4.2.2 Global Velpatasvir API Forecasted Consumption by Region (2026-2031)
4.3 North America
4.3.1 North America Velpatasvir API Consumption Growth Rate by Country: 2020 VS 2024 VS 2031
4.3.2 North America Velpatasvir API Consumption by Country (2020-2031)
4.3.3 U.S.
4.3.4 Canada
4.4 Europe
4.4.1 Europe Velpatasvir API Consumption Growth Rate by Country: 2020 VS 2024 VS 2031
4.4.2 Europe Velpatasvir API Consumption by Country (2020-2031)
4.4.3 Germany
4.4.4 France
4.4.5 U.K.
4.4.6 Italy
4.4.7 Russia
4.5 Asia Pacific
4.5.1 Asia Pacific Velpatasvir API Consumption Growth Rate by Region: 2020 VS 2024 VS 2031
4.5.2 Asia Pacific Velpatasvir API Consumption by Region (2020-2031)
4.5.3 China
4.5.4 Japan
4.5.5 South Korea
4.5.6 China Taiwan
4.5.7 Southeast Asia
4.5.8 India
4.6 Latin America, Middle East & Africa
4.6.1 Latin America, Middle East & Africa Velpatasvir API Consumption Growth Rate by Country: 2020 VS 2024 VS 2031
4.6.2 Latin America, Middle East & Africa Velpatasvir API Consumption by Country (2020-2031)
4.6.3 Mexico
4.6.4 Brazil
4.6.5 Turkey
4.6.6 GCC Countries
5 Segment by Type
5.1 Global Velpatasvir API Production by Type (2020-2031)
5.1.1 Global Velpatasvir API Production by Type (2020-2025)
5.1.2 Global Velpatasvir API Production by Type (2026-2031)
5.1.3 Global Velpatasvir API Production Market Share by Type (2020-2031)
5.2 Global Velpatasvir API Production Value by Type (2020-2031)
5.2.1 Global Velpatasvir API Production Value by Type (2020-2025)
5.2.2 Global Velpatasvir API Production Value by Type (2026-2031)
5.2.3 Global Velpatasvir API Production Value Market Share by Type (2020-2031)
5.3 Global Velpatasvir API Price by Type (2020-2031)
6 Segment by Application
6.1 Global Velpatasvir API Production by Application (2020-2031)
6.1.1 Global Velpatasvir API Production by Application (2020-2025)
6.1.2 Global Velpatasvir API Production by Application (2026-2031)
6.1.3 Global Velpatasvir API Production Market Share by Application (2020-2031)
6.2 Global Velpatasvir API Production Value by Application (2020-2031)
6.2.1 Global Velpatasvir API Production Value by Application (2020-2025)
6.2.2 Global Velpatasvir API Production Value by Application (2026-2031)
6.2.3 Global Velpatasvir API Production Value Market Share by Application (2020-2031)
6.3 Global Velpatasvir API Price by Application (2020-2031)
7 Key Companies Profiled
7.1 Mylan
7.1.1 Mylan Velpatasvir API Company Information
7.1.2 Mylan Velpatasvir API Product Portfolio
7.1.3 Mylan Velpatasvir API Production, Value, Price and Gross Margin (2020-2025)
7.1.4 Mylan Main Business and Markets Served
7.1.5 Mylan Recent Developments/Updates
7.2 NEWEDGE Overseas
7.2.1 NEWEDGE Overseas Velpatasvir API Company Information
7.2.2 NEWEDGE Overseas Velpatasvir API Product Portfolio
7.2.3 NEWEDGE Overseas Velpatasvir API Production, Value, Price and Gross Margin (2020-2025)
7.2.4 NEWEDGE Overseas Main Business and Markets Served
7.2.5 NEWEDGE Overseas Recent Developments/Updates
7.3 Hetero Drugs
7.3.1 Hetero Drugs Velpatasvir API Company Information
7.3.2 Hetero Drugs Velpatasvir API Product Portfolio
7.3.3 Hetero Drugs Velpatasvir API Production, Value, Price and Gross Margin (2020-2025)
7.3.4 Hetero Drugs Main Business and Markets Served
7.3.5 Hetero Drugs Recent Developments/Updates
7.4 Mangalam Drugs & Organics Ltd
7.4.1 Mangalam Drugs & Organics Ltd Velpatasvir API Company Information
7.4.2 Mangalam Drugs & Organics Ltd Velpatasvir API Product Portfolio
7.4.3 Mangalam Drugs & Organics Ltd Velpatasvir API Production, Value, Price and Gross Margin (2020-2025)
7.4.4 Mangalam Drugs & Organics Ltd Main Business and Markets Served
7.4.5 Mangalam Drugs & Organics Ltd Recent Developments/Updates
7.5 Aspen Biopharma Labs
7.5.1 Aspen Biopharma Labs Velpatasvir API Company Information
7.5.2 Aspen Biopharma Labs Velpatasvir API Product Portfolio
7.5.3 Aspen Biopharma Labs Velpatasvir API Production, Value, Price and Gross Margin (2020-2025)
7.5.4 Aspen Biopharma Labs Main Business and Markets Served
7.5.5 Aspen Biopharma Labs Recent Developments/Updates
7.6 Aspire Lifesciences Pvt Ltd
7.6.1 Aspire Lifesciences Pvt Ltd Velpatasvir API Company Information
7.6.2 Aspire Lifesciences Pvt Ltd Velpatasvir API Product Portfolio
7.6.3 Aspire Lifesciences Pvt Ltd Velpatasvir API Production, Value, Price and Gross Margin (2020-2025)
7.6.4 Aspire Lifesciences Pvt Ltd Main Business and Markets Served
7.6.5 Aspire Lifesciences Pvt Ltd Recent Developments/Updates
7.7 Changzhou Pharmaceutical Factory
7.7.1 Changzhou Pharmaceutical Factory Velpatasvir API Company Information
7.7.2 Changzhou Pharmaceutical Factory Velpatasvir API Product Portfolio
7.7.3 Changzhou Pharmaceutical Factory Velpatasvir API Production, Value, Price and Gross Margin (2020-2025)
7.7.4 Changzhou Pharmaceutical Factory Main Business and Markets Served
7.7.5 Changzhou Pharmaceutical Factory Recent Developments/Updates
7.8 Bulat Pharmaceutical
7.8.1 Bulat Pharmaceutical Velpatasvir API Company Information
7.8.2 Bulat Pharmaceutical Velpatasvir API Product Portfolio
7.8.3 Bulat Pharmaceutical Velpatasvir API Production, Value, Price and Gross Margin (2020-2025)
7.8.4 Bulat Pharmaceutical Main Business and Markets Served
7.8.5 Bulat Pharmaceutical Recent Developments/Updates
8 Industry Chain and Sales Channels Analysis
8.1 Velpatasvir API Industry Chain Analysis
8.2 Velpatasvir API Raw Material Supply Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.3 Velpatasvir API Production Mode & Process Analysis
8.4 Velpatasvir API Sales and Marketing
8.4.1 Velpatasvir API Sales Channels
8.4.2 Velpatasvir API Distributors
8.5 Velpatasvir API Customer Analysis
9 Velpatasvir API Market Dynamics
9.1 Velpatasvir API Industry Trends
9.2 Velpatasvir API Market Drivers
9.3 Velpatasvir API Market Challenges
9.4 Velpatasvir API Market Restraints
10 Research Findings and Conclusion
11 Methodology and Data Source
11.1 Methodology/Research Approach
11.1.1 Research Programs/Design
11.1.2 Market Size Estimation
11.1.3 Market Breakdown and Data Triangulation
11.2 Data Source
11.2.1 Secondary Sources
11.2.2 Primary Sources
11.3 Author List
11.4 Disclaimer
List of Tables
 Table 1. Global Velpatasvir API Market Value by Type, (US$ Million) & (2024 VS 2031)
 Table 2. Global Velpatasvir API Market Value by Application, (US$ Million) & (2024 VS 2031)
 Table 3. Global Velpatasvir API Production Capacity (Kg) by Manufacturers in 2024
 Table 4. Global Velpatasvir API Production by Manufacturers (2020-2025) & (Kg)
 Table 5. Global Velpatasvir API Production Market Share by Manufacturers (2020-2025)
 Table 6. Global Velpatasvir API Production Value by Manufacturers (2020-2025) & (US$ Million)
 Table 7. Global Velpatasvir API Production Value Share by Manufacturers (2020-2025)
 Table 8. Global Key Players of Velpatasvir API, Industry Ranking, 2023 VS 2024
 Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Production Value in Velpatasvir API as of 2024)
 Table 10. Global Market Velpatasvir API Average Price by Manufacturers (US$/Kg) & (2020-2025)
 Table 11. Global Key Manufacturers of Velpatasvir API, Manufacturing Base Distribution and Headquarters
 Table 12. Global Key Manufacturers of Velpatasvir API, Product Offered and Application
 Table 13. Global Key Manufacturers of Velpatasvir API, Date of Enter into This Industry
 Table 14. Global Velpatasvir API Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 15. Mergers & Acquisitions, Expansion Plans
 Table 16. Global Velpatasvir API Production Value by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 17. Global Velpatasvir API Production Value (US$ Million) by Region (2020-2025)
 Table 18. Global Velpatasvir API Production Value Market Share by Region (2020-2025)
 Table 19. Global Velpatasvir API Production Value (US$ Million) Forecast by Region (2026-2031)
 Table 20. Global Velpatasvir API Production Value Market Share Forecast by Region (2026-2031)
 Table 21. Global Velpatasvir API Production Comparison by Region: 2020 VS 2024 VS 2031 (Kg)
 Table 22. Global Velpatasvir API Production (Kg) by Region (2020-2025)
 Table 23. Global Velpatasvir API Production Market Share by Region (2020-2025)
 Table 24. Global Velpatasvir API Production (Kg) Forecast by Region (2026-2031)
 Table 25. Global Velpatasvir API Production Market Share Forecast by Region (2026-2031)
 Table 26. Global Velpatasvir API Market Average Price (US$/Kg) by Region (2020-2025)
 Table 27. Global Velpatasvir API Market Average Price (US$/Kg) by Region (2026-2031)
 Table 28. Global Velpatasvir API Consumption Growth Rate by Region: 2020 VS 2024 VS 2031 (Kg)
 Table 29. Global Velpatasvir API Consumption by Region (2020-2025) & (Kg)
 Table 30. Global Velpatasvir API Consumption Market Share by Region (2020-2025)
 Table 31. Global Velpatasvir API Forecasted Consumption by Region (2026-2031) & (Kg)
 Table 32. Global Velpatasvir API Forecasted Consumption Market Share by Region (2026-2031)
 Table 33. North America Velpatasvir API Consumption Growth Rate by Country: 2020 VS 2024 VS 2031 (Kg)
 Table 34. North America Velpatasvir API Consumption by Country (2020-2025) & (Kg)
 Table 35. North America Velpatasvir API Consumption by Country (2026-2031) & (Kg)
 Table 36. Europe Velpatasvir API Consumption Growth Rate by Country: 2020 VS 2024 VS 2031 (Kg)
 Table 37. Europe Velpatasvir API Consumption by Country (2020-2025) & (Kg)
 Table 38. Europe Velpatasvir API Consumption by Country (2026-2031) & (Kg)
 Table 39. Asia Pacific Velpatasvir API Consumption Growth Rate by Region: 2020 VS 2024 VS 2031 (Kg)
 Table 40. Asia Pacific Velpatasvir API Consumption by Region (2020-2025) & (Kg)
 Table 41. Asia Pacific Velpatasvir API Consumption by Region (2026-2031) & (Kg)
 Table 42. Latin America, Middle East & Africa Velpatasvir API Consumption Growth Rate by Country: 2020 VS 2024 VS 2031 (Kg)
 Table 43. Latin America, Middle East & Africa Velpatasvir API Consumption by Country (2020-2025) & (Kg)
 Table 44. Latin America, Middle East & Africa Velpatasvir API Consumption by Country (2026-2031) & (Kg)
 Table 45. Global Velpatasvir API Production (Kg) by Type (2020-2025)
 Table 46. Global Velpatasvir API Production (Kg) by Type (2026-2031)
 Table 47. Global Velpatasvir API Production Market Share by Type (2020-2025)
 Table 48. Global Velpatasvir API Production Market Share by Type (2026-2031)
 Table 49. Global Velpatasvir API Production Value (US$ Million) by Type (2020-2025)
 Table 50. Global Velpatasvir API Production Value (US$ Million) by Type (2026-2031)
 Table 51. Global Velpatasvir API Production Value Market Share by Type (2020-2025)
 Table 52. Global Velpatasvir API Production Value Market Share by Type (2026-2031)
 Table 53. Global Velpatasvir API Price (US$/Kg) by Type (2020-2025)
 Table 54. Global Velpatasvir API Price (US$/Kg) by Type (2026-2031)
 Table 55. Global Velpatasvir API Production (Kg) by Application (2020-2025)
 Table 56. Global Velpatasvir API Production (Kg) by Application (2026-2031)
 Table 57. Global Velpatasvir API Production Market Share by Application (2020-2025)
 Table 58. Global Velpatasvir API Production Market Share by Application (2026-2031)
 Table 59. Global Velpatasvir API Production Value (US$ Million) by Application (2020-2025)
 Table 60. Global Velpatasvir API Production Value (US$ Million) by Application (2026-2031)
 Table 61. Global Velpatasvir API Production Value Market Share by Application (2020-2025)
 Table 62. Global Velpatasvir API Production Value Market Share by Application (2026-2031)
 Table 63. Global Velpatasvir API Price (US$/Kg) by Application (2020-2025)
 Table 64. Global Velpatasvir API Price (US$/Kg) by Application (2026-2031)
 Table 65. Mylan Velpatasvir API Company Information
 Table 66. Mylan Velpatasvir API Specification and Application
 Table 67. Mylan Velpatasvir API Production (Kg), Value (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)
 Table 68. Mylan Main Business and Markets Served
 Table 69. Mylan Recent Developments/Updates
 Table 70. NEWEDGE Overseas Velpatasvir API Company Information
 Table 71. NEWEDGE Overseas Velpatasvir API Specification and Application
 Table 72. NEWEDGE Overseas Velpatasvir API Production (Kg), Value (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)
 Table 73. NEWEDGE Overseas Main Business and Markets Served
 Table 74. NEWEDGE Overseas Recent Developments/Updates
 Table 75. Hetero Drugs Velpatasvir API Company Information
 Table 76. Hetero Drugs Velpatasvir API Specification and Application
 Table 77. Hetero Drugs Velpatasvir API Production (Kg), Value (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)
 Table 78. Hetero Drugs Main Business and Markets Served
 Table 79. Hetero Drugs Recent Developments/Updates
 Table 80. Mangalam Drugs & Organics Ltd Velpatasvir API Company Information
 Table 81. Mangalam Drugs & Organics Ltd Velpatasvir API Specification and Application
 Table 82. Mangalam Drugs & Organics Ltd Velpatasvir API Production (Kg), Value (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)
 Table 83. Mangalam Drugs & Organics Ltd Main Business and Markets Served
 Table 84. Mangalam Drugs & Organics Ltd Recent Developments/Updates
 Table 85. Aspen Biopharma Labs Velpatasvir API Company Information
 Table 86. Aspen Biopharma Labs Velpatasvir API Specification and Application
 Table 87. Aspen Biopharma Labs Velpatasvir API Production (Kg), Value (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)
 Table 88. Aspen Biopharma Labs Main Business and Markets Served
 Table 89. Aspen Biopharma Labs Recent Developments/Updates
 Table 90. Aspire Lifesciences Pvt Ltd Velpatasvir API Company Information
 Table 91. Aspire Lifesciences Pvt Ltd Velpatasvir API Specification and Application
 Table 92. Aspire Lifesciences Pvt Ltd Velpatasvir API Production (Kg), Value (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)
 Table 93. Aspire Lifesciences Pvt Ltd Main Business and Markets Served
 Table 94. Aspire Lifesciences Pvt Ltd Recent Developments/Updates
 Table 95. Changzhou Pharmaceutical Factory Velpatasvir API Company Information
 Table 96. Changzhou Pharmaceutical Factory Velpatasvir API Specification and Application
 Table 97. Changzhou Pharmaceutical Factory Velpatasvir API Production (Kg), Value (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)
 Table 98. Changzhou Pharmaceutical Factory Main Business and Markets Served
 Table 99. Changzhou Pharmaceutical Factory Recent Developments/Updates
 Table 100. Bulat Pharmaceutical Velpatasvir API Company Information
 Table 101. Bulat Pharmaceutical Velpatasvir API Specification and Application
 Table 102. Bulat Pharmaceutical Velpatasvir API Production (Kg), Value (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)
 Table 103. Bulat Pharmaceutical Main Business and Markets Served
 Table 104. Bulat Pharmaceutical Recent Developments/Updates
 Table 105. Key Raw Materials Lists
 Table 106. Raw Materials Key Suppliers Lists
 Table 107. Velpatasvir API Distributors List
 Table 108. Velpatasvir API Customers List
 Table 109. Velpatasvir API Market Trends
 Table 110. Velpatasvir API Market Drivers
 Table 111. Velpatasvir API Market Challenges
 Table 112. Velpatasvir API Market Restraints
 Table 113. Research Programs/Design for This Report
 Table 114. Key Data Information from Secondary Sources
 Table 115. Key Data Information from Primary Sources
 Table 116. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Velpatasvir API
 Figure 2. Global Velpatasvir API Market Value by Type, (US$ Million) & (2020-2031)
 Figure 3. Global Velpatasvir API Market Share by Type: 2024 VS 2031
 Figure 4. Above 98 % Product Picture
 Figure 5. Above 99 % Product Picture
 Figure 6. Global Velpatasvir API Market Value by Application, (US$ Million) & (2020-2031)
 Figure 7. Global Velpatasvir API Market Share by Application: 2024 VS 2031
 Figure 8. Tablets
 Figure 9. Others
 Figure 10. Global Velpatasvir API Production Value (US$ Million), 2020 VS 2024 VS 2031
 Figure 11. Global Velpatasvir API Production Value (US$ Million) & (2020-2031)
 Figure 12. Global Velpatasvir API Production Capacity (Kg) & (2020-2031)
 Figure 13. Global Velpatasvir API Production (Kg) & (2020-2031)
 Figure 14. Global Velpatasvir API Average Price (US$/Kg) & (2020-2031)
 Figure 15. Velpatasvir API Report Years Considered
 Figure 16. Velpatasvir API Production Share by Manufacturers in 2024
 Figure 17. Global Velpatasvir API Production Value Share by Manufacturers (2024)
 Figure 18. Velpatasvir API Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 19. The Global 5 and 10 Largest Players: Market Share by Velpatasvir API Revenue in 2024
 Figure 20. Global Velpatasvir API Production Value by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Figure 21. Global Velpatasvir API Production Value Market Share by Region: 2020 VS 2024 VS 2031
 Figure 22. Global Velpatasvir API Production Comparison by Region: 2020 VS 2024 VS 2031 (Kg)
 Figure 23. Global Velpatasvir API Production Market Share by Region: 2020 VS 2024 VS 2031
 Figure 24. North America Velpatasvir API Production Value (US$ Million) Growth Rate (2020-2031)
 Figure 25. India Velpatasvir API Production Value (US$ Million) Growth Rate (2020-2031)
 Figure 26. China Velpatasvir API Production Value (US$ Million) Growth Rate (2020-2031)
 Figure 27. Global Velpatasvir API Consumption by Region: 2020 VS 2024 VS 2031 (Kg)
 Figure 28. Global Velpatasvir API Consumption Market Share by Region: 2020 VS 2024 VS 2031
 Figure 29. North America Velpatasvir API Consumption and Growth Rate (2020-2031) & (Kg)
 Figure 30. North America Velpatasvir API Consumption Market Share by Country (2020-2031)
 Figure 31. U.S. Velpatasvir API Consumption and Growth Rate (2020-2031) & (Kg)
 Figure 32. Canada Velpatasvir API Consumption and Growth Rate (2020-2031) & (Kg)
 Figure 33. Europe Velpatasvir API Consumption and Growth Rate (2020-2031) & (Kg)
 Figure 34. Europe Velpatasvir API Consumption Market Share by Country (2020-2031)
 Figure 35. Germany Velpatasvir API Consumption and Growth Rate (2020-2031) & (Kg)
 Figure 36. France Velpatasvir API Consumption and Growth Rate (2020-2031) & (Kg)
 Figure 37. U.K. Velpatasvir API Consumption and Growth Rate (2020-2031) & (Kg)
 Figure 38. Italy Velpatasvir API Consumption and Growth Rate (2020-2031) & (Kg)
 Figure 39. Russia Velpatasvir API Consumption and Growth Rate (2020-2031) & (Kg)
 Figure 40. Asia Pacific Velpatasvir API Consumption and Growth Rate (2020-2031) & (Kg)
 Figure 41. Asia Pacific Velpatasvir API Consumption Market Share by Region (2020-2031)
 Figure 42. China Velpatasvir API Consumption and Growth Rate (2020-2031) & (Kg)
 Figure 43. Japan Velpatasvir API Consumption and Growth Rate (2020-2031) & (Kg)
 Figure 44. South Korea Velpatasvir API Consumption and Growth Rate (2020-2031) & (Kg)
 Figure 45. China Taiwan Velpatasvir API Consumption and Growth Rate (2020-2031) & (Kg)
 Figure 46. Southeast Asia Velpatasvir API Consumption and Growth Rate (2020-2031) & (Kg)
 Figure 47. India Velpatasvir API Consumption and Growth Rate (2020-2031) & (Kg)
 Figure 48. Latin America, Middle East & Africa Velpatasvir API Consumption and Growth Rate (2020-2031) & (Kg)
 Figure 49. Latin America, Middle East & Africa Velpatasvir API Consumption Market Share by Country (2020-2031)
 Figure 50. Mexico Velpatasvir API Consumption and Growth Rate (2020-2031) & (Kg)
 Figure 51. Brazil Velpatasvir API Consumption and Growth Rate (2020-2031) & (Kg)
 Figure 52. Turkey Velpatasvir API Consumption and Growth Rate (2020-2031) & (Kg)
 Figure 53. GCC Countries Velpatasvir API Consumption and Growth Rate (2020-2031) & (Kg)
 Figure 54. Global Production Market Share of Velpatasvir API by Type (2020-2031)
 Figure 55. Global Production Value Market Share of Velpatasvir API by Type (2020-2031)
 Figure 56. Global Velpatasvir API Price (US$/Kg) by Type (2020-2031)
 Figure 57. Global Production Market Share of Velpatasvir API by Application (2020-2031)
 Figure 58. Global Production Value Market Share of Velpatasvir API by Application (2020-2031)
 Figure 59. Global Velpatasvir API Price (US$/Kg) by Application (2020-2031)
 Figure 60. Velpatasvir API Value Chain
 Figure 61. Channels of Distribution (Direct Vs Distribution)
 Figure 62. Bottom-up and Top-down Approaches for This Report
 Figure 63. Data Triangulation
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

SIS Group of Schools